FDA approves needle-free injector for Tev-Tropin

The FDA has approved Tev-Tropin (somatropin [rDNA] for injection, from Teva) for administration by needle-free injection. The needle-free device, by Antares Pharma, will be marketed by Teva as the Tev-Tropin Tjet Injector system.

Tev-Tropin is indicated for the treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone (GH).

For more information call (800) 292-4283 or visit www.tev-tropin.com.